Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
December-2026 Volume 25 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2026 Volume 25 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Mechanistic insights into lncRNA SNHG6 during the progression of osteoarthritis

  • Authors:
    • Feiri Huang
    • Zhongliang Su
    • Jie Yang
    • Xizhen Zhao
  • View Affiliations / Copyright

    Affiliations: Department of Orthopedics, Wenzhou People's Hospital, Wenzhou, Zhejiang 325000, P.R. China, Department of Orthopedics, Wenzhou People's Hospital, Wenzhou, Zhejiang 325000, P.R. China
    Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 148
    |
    Published online on: October 29, 2026
       https://doi.org/10.3892/br.2026.2221
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

The present study investigated the role and preliminary regulatory mechanism of the long non‑coding RNA small nucleolar RNA host gene 6 (SNHG6) in lipopolysaccharide (LPS)‑induced chondrocytes. LPS‑induced chondrocytes were used to mimic osteoarthritis (OA) in vitro. Gain‑ and loss‑of‑function experiments were performed as follows: the Cell Counting Kit‑8 assay for cell viability, flow cytometry for cell cycle and apoptosis analysis, the TUNEL assay for further apoptosis detection, western blotting for apoptosis‑ and cell cycle‑related protein levels, and ELISA for inflammatory cytokine levels. Gene expression levels were detected by reverse transcription‑quantitative PCR and immunofluorescence. In LPS‑induced chondrocytes and in patients with OA, reduced expression of SNHG6 and PGAP1 as well as increase expression of microRNA (miR)‑944 were observed. SNHG6 targets miR‑944, and PGAP1 is a target of miR‑944. Overexpression of SNHG6 or PGAP1, as well as downregulation of miR‑944 markedly suppressed chondrocyte apoptosis and inflammation. Furthermore, increased miR‑944 expression reversed the regulatory effects of PGAP1 overexpression in LPS‑induced chondrocytes. In conclusion, the role and underlying mechanism of SNHG6 in the progression of OA in vitro were preliminarily identified, and it was found that its overexpression remarkably inhibits chondrocyte apoptosis and inflammation. This regulatory effect may be mediated by regulating the miR‑944/PGAP1 axis.
View Figures

Figure 1

Effects of SNHG6 expression on
LPS-stimulated chondrocytes. (A) The expression of SNHG6 in
synovial fluid of normal individuals and patients with
osteoarthritis was detected via RT-qPCR. (B) Following transfection
of si-SNHG6 or OE-SNHG6 in LPS-induced chondrocytes, the expression
of SNHG6 was detected via RT-qPCR. (C) The viability of LPS-induced
chondrocytes that transfected with si-SNHG6 or OE-SNHG6 was
measured by Cell Counting Kit-8 assay. (D and E) Cell frequency of
LPS-induced chondrocytes was calculated via flow cytometric
analysis. (F and G) The percentages of TUNEL-positive cells were
assessed by TUNEL assay. Scale bar, 100 µm. (H and I) The apoptotic
rate of LPS-induced chondrocytes was calculated via flow cytometric
analysis. (J) The protein levels of Caspase-3, Caspase-9, Cyclin
A1, Cyclin B1 and Cyclin D2 in LPS-induced chondrocytes that
transfected with si-SNHG6 or OE-SNHG6 were determined via western
blotting. (K) The levels of IL-6, TNF-α and IL-1β in LPS-induced
chondrocytes that transfected with si-SNHG6 or OE-SNHG6 were
determined via ELISA. *P<0.05,
**P<0.01, ***P<0.001 and
****P<0.0001. SNHG6, small nucleolar RNA host gene 6;
LPS, lipopolysaccharide; RT-qPCR, reverse
transcription-quantitative PCR; si-, small interfering; OE-,
overexpression; ns, no significance; NC, negative control.

Figure 2

SNHG6 binds to and negatively
regulates miR-944. (A) StarBase showed the predicted binding site
of SNHG6 and miR-944. (B) The luciferase activities in chondrocytes
co-transfected with pGL3-SNHG6-Wt/pGL3-SNHG6-Mut and miR-944
mimics/mimics NC were determined by dual luciferase reporter assay.
(C) The expression of miR-944 in synovial fluid of normal
individuals and patients with osteoarthritis was detected via
RT-qPCR. (D) Following transfection of si-SNHG6 or OE-SNHG6 in
LPS-induced chondrocytes, the expression of miR-944 was detected
via RT-qPCR. (E and F) Following transfection of OE-SNHG6 or
miR-944 mimics in LPS-induced chondrocytes, the expression of (E)
miR-944 and (F) SNHG6 was detected via RT-qPCR. (G-L) Following
transfection of OE-SNHG6 or miR-944 mimics in LPS-induced
chondrocytes, (G) cell viability, (H and I) apoptosis and (J-L)
inflammatory cytokine levels were determined.
*P<0.05, **P<0.01,
***P<0.001 and ****P<0.0001. SNHG6,
small nucleolar RNA host gene 6; miR, microRNA; NC, negative
control; RT-qPCR, reverse transcription-quantitative PCR; si-,
small interfering; OE-, overexpression; LPS, lipopolysaccharide;
ns, no significance.

Figure 3

Effects of miR-944 inhibition on
LPS-stimulated chondrocytes. (A) Following transfection of miR-944
inhibitor or inhibitor NC in LPS-induced chondrocytes, the
expression of miR-944 was detected via reverse
transcription-quantitative PCR. (B) The viability of LPS-induced
chondrocytes that transfected with miR-944 inhibitor or inhibitor
NC was measured by Cell Counting Kit-8 assay. (C) Cell frequency of
LPS-induced chondrocytes was calculated via flow cytometric
analysis. (D) The percentages of TUNEL-positive cells were assessed
by TUNEL assay. Scale bar, 100 µm. (E) The apoptotic rate of
LPS-induced chondrocytes was calculated via flow cytometric
analysis. (F) The protein levels of Caspase-3, Caspase-9, Cyclin
A1, Cyclin B1 and Cyclin D2 in LPS-induced chondrocytes that
transfected with miR-944 inhibitor or inhibitor NC were determined
via western blotting. (G) The levels of IL-6, TNF-α and IL-1β in
LPS-induced chondrocytes that transfected with miR-944 inhibitor or
inhibitor NC were determined via ELISA. *P<0.05,
**P<0.01, ***P<0.001 and
****P<0.0001. miR, microRNA; LPS, lipopolysaccharide;
NC, negative control.

Figure 4

PGAP1 is a direct downstream target
of miR-944. (A) StarBase showed the predicted binding site of
miR-944 and PGAP1. (B) The target relationship between miR-944 and
PGAP1 was verified by dual luciferase reporter assay in
chondrocytes. (C) The expression of PGAP1 in synovial fluid of
normal individuals and patients with osteoarthritis was detected
via RT-qPCR. (D and E) Following transfection of miR-944 inhibitor
or miR-944 mimics, the expression of (D) miR-944 and (E) PGAP1 in
chondrocytes was detected by RT-qPCR. (F-I) Following transfection
of (F and G) OE-PGAP1/miR-944 mimics or (H and I) si-PGAP1/miR-944
inhibitor, the expression of PGAP1 in LPS-induced chondrocytes was
detected by immunofluorescence tests. Scale bar, 100 µm. (J and K)
Following transfection of si-SNHG6 or OE-SNHG6, the expression of
PGAP1 in LPS-induced chondrocytes was detected by
immunofluorescence tests. Scale bar, 100 µm. (L) Following
transfection of OE-SNHG6 or miR-944 mimics, the expression of PGAP1
in LPS-induced chondrocytes was detected by RT-qPCR. ns: no
significance. *P<0.05, **P<0.01,
***P<0.001 and ****P<0.0001. PGAP1,
post-GPI attachment to protein 1; miR, microRNA; RT-qPCR, reverse
transcription-quantitative PCR; si-, small interfering; OE-,
overexpression; LPS, lipopolysaccharide; NC, negative control; ns,
no significance.

Figure 5

miR-944 interacts with PGAP1 to
modulate proliferation, apoptosis and inflammation in
LPS-stimulated chondrocytes. Following transfection of OE-PGAP1 or
miR-944 mimics, (A) the viability of LPS-induced chondrocytes was
measured by Cell Counting Kit-8 assay. (B) Cell frequency of
LPS-induced chondrocytes was calculated via flow cytometric
analysis. (C) The apoptotic rate of LPS-induced chondrocytes was
calculated via flow cytometric analysis. (D and E) The percentages
of TUNEL-positive cells were assessed by TUNEL assay. Scale bar,
100 µm. (F) The protein levels of Caspase-3, Caspase-9, Cyclin A1,
Cyclin B1 and Cyclin D2 in LPS-induced chondrocytes were determined
via western blotting. (G) The levels of IL-6, TNF-α and IL-1β in
LPS-induced chondrocytes were determined via ELISA.
*P<0.05, **P<0.01,
***P<0.001 and ****P<0.0001. miR,
microRNA; PGAP1, post-GPI attachment to protein 1; LPS,
lipopolysaccharide; OE-, overexpression; NC, negative control; ns,
no significance.
View References

1 

Yao Q, Wu X, Tao C, Gong W, Chen M, Qu M, Zhong Y, He T, Chen S and Xiao G: Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct Target Ther. 8(56)2023.PubMed/NCBI View Article : Google Scholar

2 

GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: A systematic analysis for the Global burden of disease study 2021. Lancet Rheumatol. 5:e508–e522. 2023.PubMed/NCBI View Article : Google Scholar

3 

Xiao SQ, Cheng M, Wang L, Cao J, Fang L, Zhou XP, He XJ and Hu YF: The role of apoptosis in the pathogenesis of osteoarthritis. Int Orthop. 47:1895–1919. 2023.PubMed/NCBI View Article : Google Scholar

4 

Sanchez-Lopez E, Coras R, Torres A, Lane NE and Guma M: Synovial inflammation in osteoarthritis progression. Nat Rev Rheumatol. 18:258–275. 2022.PubMed/NCBI View Article : Google Scholar

5 

Oo WM and Hunter DJ: Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs). Ther Adv Musculoskelet Dis. 14(1759720X221090297)2022.PubMed/NCBI View Article : Google Scholar

6 

Oo WM and Hunter J: Intra-articular Therapies for Knee Osteoarthritis: Current Update. Curr Treat Options Rheum. 9:99–119. 2023.

7 

Winkle M, El-Daly SM, Fabbri M and Calin GA: Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov. 20:629–651. 2021.PubMed/NCBI View Article : Google Scholar

8 

Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, Chen R, Dean C, Dinger ME, Fitzgerald KA, et al: Long non-coding RNAs: Definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 24:430–447. 2023.PubMed/NCBI View Article : Google Scholar

9 

Shi M, Sun M, Wang C, Shen Y, Wang Y and Yan S: Therapeutic potential of POU3F3, a novel long non-coding RNA, alleviates the pathogenesis of osteoarthritis by regulating the miR-29a- 3p/FOXO3 axis. Curr Gene Ther. 22:427–438. 2022.PubMed/NCBI View Article : Google Scholar

10 

Chen X, Liu J, Sun Y, Wen J, Zhou Q, Ding X and Zhang X: Correlation analysis of differentially expressed long non-coding RNA HOTAIR with PTEN/PI3K/AKT pathway and inflammation in patients with osteoarthritis and the effect of baicalin intervention. J Orthop Surg Res. 18(34)2023.PubMed/NCBI View Article : Google Scholar

11 

Ni C, Zhang W, Qiu S, Cheng H and Ma C: Long non-coding RNA DLEU1 promotes progression of osteoarthritis via miR-492/TLR8 Axis. Curr Pharm Biotechnol. 25:2166–2181. 2024.PubMed/NCBI View Article : Google Scholar

12 

Zhang S, Qiu D, Xie X and Shen Y: Clinicopathological and prognostic value of SNHG6 in cancers: A systematic review and a meta-analysis. BMC Cancer. 20(343)2020.PubMed/NCBI View Article : Google Scholar

13 

Jurkiewicz M, Szczepaniak A and Zielinska M: Long non-coding RNAs - SNHG6 emerge as potential marker in colorectal cancer. Biochim Biophys Acta Rev Cancer. 1879(189056)2024.PubMed/NCBI View Article : Google Scholar

14 

Wang J, Si J, Zhao Z, Gao C, Liu T, Jia Y and Liu L: SNHG6 facilitates the epithelial-mesenchymal transition and metastatic potential of esophageal squamous carcinoma through miR-26b-5p/ITGB1 axis. Sci Rep. 14(25005)2024.PubMed/NCBI View Article : Google Scholar

15 

Su M, Huang P and Li Q: Long noncoding RNA SNHG6 promotes the malignant phenotypes of ovarian cancer cells via miR-543/YAP1 pathway. Heliyon. 9(e16291)2023.PubMed/NCBI View Article : Google Scholar

16 

Zhang Y, Qiao Z, He M and Xia J: OGT promotes the ferroptosis of chondrocytes in osteoarthritis development via O-GlcNAcylation modification of ACSF2. Immunol Res. 73(7)2024.PubMed/NCBI View Article : Google Scholar

17 

Wang J, Li J, Hong Z and Deng H: Circ_0004662 promotes lipopolysaccharide-induced osteoarthritis by targeting the miR-450b-5p/TCF4 axis. Clin Rheumatol. 45:1865–1876. 2026.PubMed/NCBI View Article : Google Scholar

18 

Zhang H, Xiao J, Yi Y, Chen B, Lv W, Ma J, Lin Y, Wu Y, Meng K, Cai Y, et al: Homoplantaginin ameliorates osteoarthritis by activating Sirt3/PINK1/Parkin signaling to promote mitophagy and attenuate inflammation in chondrocytes. Phytomedicine. 153(157959)2026.PubMed/NCBI View Article : Google Scholar

19 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

20 

Li Y, Xie W, Xiao W and Dou D: Progress in osteoarthritis research by the National natural science foundation of China. Bone Res. 10(41)2022.PubMed/NCBI View Article : Google Scholar

21 

Kang Y, Liu C, Ji Y, Zhang H, Wang Y, Bi W, Xu J and Guo B: The burden of knee osteoarthritis worldwide, regionally, and nationally from 1990 to. 2019, along with an analysis of cross-national inequalities. Arch Orthop Trauma Surg. 144:2731–2743. 2024.PubMed/NCBI View Article : Google Scholar

22 

Hawker GA and King LK: The burden of osteoarthritis in older adults. Clin Geriatr Med. 38:181–192. 2022.PubMed/NCBI View Article : Google Scholar

23 

van den Bosch MHJ, Blom AB and van der Kraan PM: Inflammation in osteoarthritis: Our view on its presence and involvement in disease development over the years. Osteoarthritis Cartilage. 32:355–364. 2024.PubMed/NCBI View Article : Google Scholar

24 

Hung K and Cai HL: The role of chondrocyte senescence in osteoarthritis pathogenesis and therapeutic implications. Exp Gerontol. 208(112828)2025.PubMed/NCBI View Article : Google Scholar

25 

Zhou Y, Li J, Xu F, Ji E, Wang C and Pan Z: Long noncoding RNA H19 alleviates inflammation in osteoarthritis through interactions between TP53, IL-38, and IL-36 receptor. Bone Joint Res. 11:594–607. 2022.PubMed/NCBI View Article : Google Scholar

26 

Yao N, Peng S, Wu H, Liu W, Cai D and Huang D: Long noncoding RNA PVT1 promotes chondrocyte extracellular matrix degradation by acting as a sponge for miR-140 in IL-1β-stimulated chondrocytes. J Orthop Surg Res. 17(218)2022.PubMed/NCBI View Article : Google Scholar

27 

Jiang H, Pang H, Wu P, Cao Z, Li Z and Yang X: LncRNA SNHG5 promotes chondrocyte proliferation and inhibits apoptosis in osteoarthritis by regulating miR-10a-5p/H3F3B axis. Connect Tissue Res. 62:605–614. 2021.PubMed/NCBI View Article : Google Scholar

28 

Wang Q, Deng F, Li J, Guo L and Li K: The long non-coding RNA SNHG1 attenuates chondrocyte apoptosis and inflammation via the miR-195/IKK-α axis. Cell Tissue Bank. 24:167–180. 2023.PubMed/NCBI View Article : Google Scholar

29 

Tian F, Wang J, Zhang Z and Yang J: LncRNA SNHG7/miR-34a-5p/SYVN1 axis plays a vital role in proliferation, apoptosis and autophagy in osteoarthritis. Biol Res. 53(9)2020.PubMed/NCBI View Article : Google Scholar

30 

Yang X, Chen H, Zheng H, Chen K, Cai P, Li L, Li K, Du Y and He XC: LncRNA SNHG12 promotes osteoarthritis progression through targeted down-regulation of miR-16-5p. Clin Lab. 68:2022.PubMed/NCBI View Article : Google Scholar

31 

Tan D, Guo J, Wang T, Yang S, Liu J, Wang D and Li W: Chondrocyte senescence in osteoarthritis: Potential targets and pharmacological interventions. Cartilage. (19476035251414314)2026.PubMed/NCBI View Article : Google Scholar

32 

Zhao J, Zhang Z, Zuo T, Yu J, Yang S, Yang Y, Li X and Zheng J: Downregulation of miR-892b inhibits the progression of osteoarthritis via targeting cyclin D1 and cyclin D2. Exp Cell Res. 405(112683)2021.PubMed/NCBI View Article : Google Scholar

33 

Radonova L, Pauerova T, Jansova D, Danadova J, Skultety M, Kubelka M and Anger M: Cyclin A1 in oocytes prevents chromosome segregation and anaphase entry. Sci Rep. 10(7455)2020.PubMed/NCBI View Article : Google Scholar

34 

Li H, Qiao Y, Ding M and Liu Y: Targeting CCNB1 repressed cartilage degradation induced by inflammation through NF-ĸB pathway in osteoarthritis. J Histochem Cytochem. 74:235–248. 2026.PubMed/NCBI View Article : Google Scholar

35 

Lei J, Fu Y, Zhuang Y, Zhang K and Lu D: LncRNA SNHG1 alleviates IL-1β-induced osteoarthritis by inhibiting miR-16-5p-mediated p38 MAPK and NF-ĸB signaling pathways. Biosci Rep. 39(BSR20191523)2019.PubMed/NCBI View Article : Google Scholar

36 

Zhang H, Li J, Shao W and Shen N: LncRNA SNHG9 is downregulated in osteoarthritis and inhibits chondrocyte apoptosis by downregulating miR-34a through methylation. BMC Musculoskelet Disord. 21(511)2020.PubMed/NCBI View Article : Google Scholar

37 

Wang B, Li J and Tian F: Downregulation of lncRNA SNHG14 attenuates osteoarthritis by inhibiting FSTL-1 mediated NLRP3 and TLR4/NF-ĸB pathway through miR-124-3p. Life Sci. 270(119143)2021.PubMed/NCBI View Article : Google Scholar

38 

Kong H, Sun ML, Zhang XA and Wang XQ: Crosstalk among circRNA/lncRNA, miRNA, and mRNA in osteoarthritis. Front Cell Dev Biol. 9(774370)2021.PubMed/NCBI View Article : Google Scholar

39 

Shen H, Wang Y, Shi W, Sun G, Hong L and Zhang Y: LncRNA SNHG5/miR-26a/SOX2 signal axis enhances proliferation of chondrocyte in osteoarthritis. Acta Biochim Biophys Sin (Shanghai). 50:191–198. 2018.PubMed/NCBI View Article : Google Scholar

40 

Zhang X, Huang CR, Pan S, Pang Y, Chen YS, Zha GC, Guo KJ and Zheng X: Long non-coding RNA SNHG15 is a competing endogenous RNA of miR-141-3p that prevents osteoarthritis progression by upregulating BCL2L13 expression. Int Immunopharmacol. 83(106425)2020.PubMed/NCBI View Article : Google Scholar

41 

Williams C, Jiang YH, Shashi V, Crimian R, Schoch K, Harper A, McHale D, Goldstein D and Petrovski S: Additional evidence that PGAP1 loss of function causes autosomal recessive global developmental delay and encephalopathy. Clin Genet. 88:597–599. 2015.PubMed/NCBI View Article : Google Scholar

42 

Huang F, Su Z, Yang J, Zhao X and Xu Y: Downregulation of lncRNA NEAT1 interacts with miR-374b-5p/PGAP1 axis to aggravate the development of osteoarthritis. J Orthop Surg Res. 18(670)2023.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Huang F, Su Z, Yang J and Zhao X: Mechanistic insights into lncRNA SNHG6 during the progression of osteoarthritis. Biomed Rep 25: 148, 2026.
APA
Huang, F., Su, Z., Yang, J., & Zhao, X. (2026). Mechanistic insights into lncRNA SNHG6 during the progression of osteoarthritis. Biomedical Reports, 25, 148. https://doi.org/10.3892/br.2026.2221
MLA
Huang, F., Su, Z., Yang, J., Zhao, X."Mechanistic insights into lncRNA SNHG6 during the progression of osteoarthritis". Biomedical Reports 25.6 (2026): 148.
Chicago
Huang, F., Su, Z., Yang, J., Zhao, X."Mechanistic insights into lncRNA SNHG6 during the progression of osteoarthritis". Biomedical Reports 25, no. 6 (2026): 148. https://doi.org/10.3892/br.2026.2221
Copy and paste a formatted citation
x
Spandidos Publications style
Huang F, Su Z, Yang J and Zhao X: Mechanistic insights into lncRNA SNHG6 during the progression of osteoarthritis. Biomed Rep 25: 148, 2026.
APA
Huang, F., Su, Z., Yang, J., & Zhao, X. (2026). Mechanistic insights into lncRNA SNHG6 during the progression of osteoarthritis. Biomedical Reports, 25, 148. https://doi.org/10.3892/br.2026.2221
MLA
Huang, F., Su, Z., Yang, J., Zhao, X."Mechanistic insights into lncRNA SNHG6 during the progression of osteoarthritis". Biomedical Reports 25.6 (2026): 148.
Chicago
Huang, F., Su, Z., Yang, J., Zhao, X."Mechanistic insights into lncRNA SNHG6 during the progression of osteoarthritis". Biomedical Reports 25, no. 6 (2026): 148. https://doi.org/10.3892/br.2026.2221
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team